Aleract® Line

Product description

Food supplements for pregnancy, for the management of the risk of miscarriage and preterm birth.Four clinical trials demonstrate safety and efficacy of the original formulation with two of the studies demonstrating efficacy in preventing preterm birth, one highlighting its ability to reduce subchorionic hematoma, and one retrospective study confirming safety in over 600 pregnant women. One retrospective study confirms the efficacy of Aleract HA in reducing adverse outcomes, including miscarriage. There are three ongoing clinical trials for Aleract HA.

Specifications

Categories	Food Supplements / Nutraceuticals
Sales markets	Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from	Italy
Product Applications	Dietary Supplements; Food Supplements
Product Certifications	Quality assurance

More products from LO.LI. PHARMA INTERNATIONAL S.R.L.

Inofolic® Line

For the management of PCOS and fertility issues. Efficacy of the product line is supported by 60+ international clinical trials in more than 5000 patients. Many published studies demonstrate efficacy in improving metabolic and hormonal imbalance, as well as signs and symptoms of PCOS. It has also been s...

More info

Tiroxil® Line

Food supplements for the management of subclinical thyroid disorders. Nine clinical studies demonstrate, among other results, TSH reductions and autoimmunity control in patients with subclinical hypothyroidism after 6 months of treatment using the 4.0 formulation. One clinical trial demonstrates efficac...

More info

Biguanelle® Line

A solution for vaginal infections. Six clinical trials demonstrate the solution's efficacy in clearing bacterial vaginosis, candidiasis, and HPV infections. Two trials prove equivalent efficacy to antibiotics. One systematic review confirms positive results. The pessaries and gel are each supported by a...

More info

Delphys® Line

Food supplements for uterine fibroids management. Clinical efficacy is supported by six clinical trials, which demonstrate a statistically significant reduction in fibroid volume and related symptoms, with a relevant improvement in quality of life. Two clinical trials are ongoing. For Delphys Plus...

More info

Pervistop®

The food supplement for the management of persistent HPV infections. One clinical trial demonstrated a clearance of HPV in 85% of patients after 3 months of administration. One case report and one in-vitro study further support safety and efficacy, while there are two ongoing clinical trials.

More info

Santes® and Ialos®

Innovative solutions for vaginal and bladder/urogenital disorders.
Five clinical trials and one systemic review confirm safety and efficacy of Santes in various forms of vaginal atrophy, including efficacy in the prevention of acute side effects of radiotherapy after cervical surgery.
...

More info